Ovarian Cancer and Us - best viewed in FIREFOX

Google Search: this blog, links from posts and the web.....

Loading...

Tuesday, July 28, 2009

Supportive Care Trials Face Challenge of Scientific and Ethical Inadequacies



Microsatellite Instability and Mismatch Repair Protein Defects in Ovarian Epithelial Neoplasms in Patients 50 Years of Age and Younger



Microsatellite Instability and Mismatch Repair Protein Defects in Ovarian Epithelial Neoplasms in Patients 50 Years of Age and Younger: "This study demonstrates a 10% rate of MMR-deficient ovarian cancer in women <50 years of age. MMR-deficient ovarian cancer is frequently associated with loss of expression of MSH2 and MSH6 proteins and clear cell histology. The occurrence of MMR inactivation in a significant proportion of ovarian clear cell carcinomas (17% in this study) suggests that this tumor may warrant targeted testing in women < 50 years of age."

Lynch syndrome (HNPCC) and endometrial carcinoma - Journal of Clinical Pathology NOTE- reference to clear cell



PLoS Medicine: The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection



Accelerated Approval of Cancer Drugs: Improved Access to Therapeutic Breakthroughs or Early Release of Unsafe and Ineffective Drugs? -- Richey et al., 10.1200/JCO.2008.21.1961 -- Journal of Clinical Oncology



JCO Editorial: More Mastectomies: Is This What Patients Really Want?